Last reviewed · How we verify
Quertine (QUERCETIN)
Quercetin is a small molecule drug that targets aromatase, a key enzyme involved in estrogen production. It is classified as a quercetin, a type of flavonoid found in plants. Quercetin's mechanism of action involves inhibiting aromatase, which can lead to decreased estrogen levels. However, it is not FDA-approved for any indications and its commercial status is unknown. As a result, its availability and safety profile are not well-established.
At a glance
| Generic name | QUERCETIN |
|---|---|
| Target | Cytochrome P450 2C8, ELAV-like protein 3, Hypoxia-inducible factor 1-alpha inhibitor |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency (PHASE1)
- Improving Physical Ability and Cellular Senescence Elimination in HIV (PHASE2)
- Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes (PHASE2)
- Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study). (NA)
- Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects (PHASE2, PHASE3)
- A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes (NA)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Quertine CI brief — competitive landscape report
- Quertine updates RSS · CI watch RSS